Endothelium-derived hyperpolarizing factor - A critical appraisal

55Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Endothelium-derived hyperpolarizing factor is defined as that substance which produces vascular smooth muscle hyperpolarization which cannot be explained by nitric oxide or by a cyclo-oxygenase product such as prostacyclin. The possibility that the factor is an epoxyeicosatrienoic acid or a cannabinoid agonist such as anandamide continues to be investigated, but definitive evidence in favour of either is lacking. The sensitivity of EDHF- mediated responses to charybdotoxin, to apamin or to mixtures of these two toxins may indicate the opening of more than one smooth muscle K-channel, but the possibility that these are located on the vascular endothelium is discussed.

Cite

CITATION STYLE

APA

Edwards, G., & Weston, A. H. (1998). Endothelium-derived hyperpolarizing factor - A critical appraisal. Progress in Drug Research. Birkhauser Verlag AG. https://doi.org/10.1007/978-3-0348-8833-2_2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free